| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/10/2013 | US20130012381 Pyridazine Compounds for Controlling Invertebrate Pests |
| 01/10/2013 | US20130012380 Pyridazine Compounds For Controlling Invertebrate Pests |
| 01/10/2013 | US20130011361 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 01/10/2013 | US20130009142 Charge transport compositions and electronic devices made with such compositions |
| 01/10/2013 | CA2840095A1 Compounds for the treatment of hiv |
| 01/10/2013 | CA2838223A1 Fused benzoxazepinones as ion channel modulators |
| 01/10/2013 | CA2837524A1 Dihydropyrazoles |
| 01/09/2013 | EP2542550A1 Process for the direct preparation of malic acid salt of sunitinib |
| 01/09/2013 | EP2542549A2 Inhibitors of glutaminyl cyclase |
| 01/09/2013 | EP2542538A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
| 01/09/2013 | EP2542537A1 Novel compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (ror gamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 01/09/2013 | EP2542533A1 Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants |
| 01/09/2013 | EP2542525A1 Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof |
| 01/09/2013 | EP2542524A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 01/09/2013 | EP2542089A1 Nuclear transport modulatiors and uses thereof |
| 01/09/2013 | CN102869666A Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/09/2013 | CN102869657A Analogues for the treatment or prevention of flavivirus infections |
| 01/09/2013 | CN102863428A Spiro-compounds taken as hepatitis c virus (HCV) inhibitor |
| 01/09/2013 | CN102863398A Synthetic method for sartan drug intermediate and application of intermediate |
| 01/09/2013 | CN102180867B Synthesis method of N-{2-[4-(2-pyrimidyl)-1-piperazine}adamantine-1-formide |
| 01/09/2013 | CN101798298B Imidazole derivatives |
| 01/09/2013 | CN101648918B Intermediate compound of candesartan cilexetil and synthesis method thereof |
| 01/09/2013 | CN101616668B New pharmaceutical composition |
| 01/09/2013 | CN101481374B Method for removing trityl group of 1-trityl-5-(1,1'-biphenylyl-2 yl)-1H-tetrazole compound |
| 01/09/2013 | CN101407511B Crystal type glyoxaline-5-carboxyl acid derivative |
| 01/08/2013 | US8349861 Methods for identification of JAK kinase interacting molecules and for the purification of JAK kinases |
| 01/08/2013 | US8349860 Inhibitors of syk and JAK protein kinases |
| 01/08/2013 | US8349859 Pyrimidine derivatives |
| 01/08/2013 | US8349843 Carboxylic acid derivatives, their preparation and use |
| 01/08/2013 | US8349833 Compounds, compositions and methods useful for cholesterol mobilisation |
| 01/08/2013 | CA2578441C Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 01/08/2013 | CA2567574C Benzotriazine inhibitors of kinases |
| 01/08/2013 | CA2562571C Novel androgens |
| 01/08/2013 | CA2557372C Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| 01/03/2013 | WO2013002879A1 Small molecule cd38 inhibitors and methods of using same |
| 01/03/2013 | WO2013002660A2 Process |
| 01/03/2013 | WO2013001511A1 Novel salt intermediates for the synthesis of bazedoxifene acetate and process thereof |
| 01/03/2013 | WO2013001505A2 Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases |
| 01/03/2013 | WO2013001499A1 Indoleamine derivatives for the treatment of central nervous system diseases |
| 01/03/2013 | WO2013001235A1 Supported alkoxylated organotin reactant, preparation and use for heterogeneous-phase synthesis of tetrazoles |
| 01/03/2013 | WO2013001030A1 Oxazetidine derivatives, process for preparing them and use thereof in human medicine and in cosmetics |
| 01/03/2013 | WO2013000994A1 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | WO2013000943A1 Microbiocidal heterocycles |
| 01/03/2013 | WO2013000267A1 Azole heterocyclic compound, preparation method, pharmaceutical composition and use |
| 01/03/2013 | WO2013000108A1 Azole heterocylic compounds, preparation methods, pharmaceutical compositions and uses thereof |
| 01/03/2013 | WO2012138715A3 Small molecule inhibitors of xbp1 splicing |
| 01/03/2013 | WO2012088491A3 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same |
| 01/03/2013 | US20130005985 Process Using Grignard Reagents |
| 01/03/2013 | US20130005973 Process for preparing voriconazole by using new intermediates |
| 01/03/2013 | US20130005972 Application of Staudinger Ligation in PET Imaging |
| 01/03/2013 | US20130005964 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/03/2013 | US20130005963 Organic photoelectric conversion material and organic thin-film photoelectric conversion device |
| 01/03/2013 | US20130005956 Synthesis of 18F-labeled Tracers in Hydrous Organic Solvents |
| 01/03/2013 | US20130005784 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 01/03/2013 | US20130005753 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/03/2013 | US20130005739 Pharmaceutical preparations comprising a cos releasing compound |
| 01/03/2013 | US20130005738 Monocyclic Heteroaryl Compounds |
| 01/03/2013 | US20130005728 Substituted pyrimidines as prostaglandin d2 receptor antagonists |
| 01/03/2013 | US20130005727 Quinazoline derivatives |
| 01/03/2013 | US20130005702 Pyrazole derivatives as protein kinase modulators |
| 01/03/2013 | US20130004518 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 01/03/2013 | US20130004457 Hepatitis C Virus Inhibitors |
| 01/03/2013 | US20130001537 Novel organic compound and organic light-emitting device having the same |
| 01/03/2013 | US20130001524 Heterocyclic compound and organic light-emitting device comprising the same |
| 01/03/2013 | CA2840606A1 Oxazetidine derivatives, process for preparing them and use thereof in human medicine and in cosmetics |
| 01/03/2013 | CA2840516A1 Small molecule cd38 inhibitors and methods of using same |
| 01/03/2013 | CA2840332A1 Microbiocidal heterocycles |
| 01/03/2013 | CA2839655A1 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | CA2838321A1 Sulphonamide derivatives of alicyclic amines for the treatment of the central nervous system diseases |
| 01/03/2013 | CA2838314A1 Indoleamine derivatives for the treatment of central nervous system diseases |
| 01/02/2013 | EP2541635A1 Organic electroluminescent element |
| 01/02/2013 | EP2540706A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
| 01/02/2013 | EP2540705A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
| 01/02/2013 | EP2539341A1 Derivatives of 1-phenyl-1,5-dihydro-benzo[b][1.4]diazepine-2.4-dione as inhibitors of hiv replication |
| 01/02/2013 | EP2539334A1 Process for the preparation of -acyloxy -formamido amides |
| 01/02/2013 | EP2539326A1 Bisaryl-bonded aryltriazolones and use thereof |
| 01/02/2013 | EP2539320A1 A process for the preparation of substituted prolyl peptides and similar peptidomimetics |
| 01/02/2013 | EP2538784A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 01/02/2013 | CN1919846B Novel oriented synthesis method of voriconazole, medicinal salt and intermediate thereof |
| 01/02/2013 | CN102858779A Cyclic tetrapeptides and therapeutic applications thereof |
| 01/02/2013 | CN102858765A Pyrazolyl quinazoline kinase inhibitors |
| 01/02/2013 | CN102858764A Pyrimidinyl indole compounds |
| 01/02/2013 | CN102858755A 1, 2, 4-triazole derivatives and their anti mycobacterial activity |
| 01/02/2013 | CN102858754A RAF inhibitor compounds and methods of use thereof |
| 01/02/2013 | CN102858743A Spiro-condensed cyclohexane derivatives as HSL inhibitors useful for the treatment of diabetes |
| 01/02/2013 | CN102858742A Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 01/02/2013 | CN102858342A Arylvinylazacycloalkane compounds for constipation |
| 01/02/2013 | CN102850332A 1-(2,6-Dichlorophenyl)-3-n-butyl-1,4-dihydro-4-[4-[2-(1H-tetrazole-5-yl)-1H-pyrrole-1-yl]phenylmethyl]-5H-1,2,4-triazole-5-one with cardiovascular activity and synthesis process of medicinal salt thereof |
| 01/02/2013 | CN102850331A 4, 6-dichloro-2-methyl-5-(1-acetyl-2-imidazoline-2-yl)-aminopyrimidine preparation method |
| 01/02/2013 | CN102850330A Method for preparing N-substituted pyrrolidine derivative through bromination |
| 01/02/2013 | CN102850329A Triazinyl derivative compound and its application in OLED (organic light emission diode) |
| 01/02/2013 | CN102850321A Aroxylpyrimidine formamide or aroxylpyridine formamide compound and its preparation method, pharmaceutical composition, and application |
| 01/02/2013 | CN102153543B Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 01/02/2013 | CN101830889B 嘧啶衍生物 Pyrimidine derivatives |
| 01/02/2013 | CN101747321B Indole-3-benzylamine derivative, preparation method and application |
| 01/02/2013 | CN101735200B Quinazoline compound |
| 01/02/2013 | CN101675036B Dual-acting benzoimidazole antihypertensive agents |
| 01/02/2013 | CN101595084B Biaryl compositions and methods for modulating a kinase cascade |
| 01/02/2013 | CN101516856B Heterocyclic bridged biphenyls and their use in oleds |
| 01/02/2013 | CN101511797B Benzimidazole modulators of VR1 |